
Commentary|Podcasts|December 2, 2025
Breaking Down CELEBRATE and POLY-HF: Two Paths to Better Cardiac Care
Fact checked by: Ron Panarotti
Advertisement
In this solo episode, Craig Beavers breaks down new data from the CELEBRATE STEMI (NCT04825743) trial and the POLY-HF (NCT04633005) polypill study. He highlights what these findings could mean for real-world practice, from early antiplatelet strategies to improving adherence and outcomes in heart failure.
Show Notes:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nipah Outbreak in India Poses Low Global Risk Despite Lack of Approved Treatments
2
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
3
Q&A: Making Plant-Based Eating Practical in Pharmacy-Led Cardiometabolic Care
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























